Using a pHA130 filter for 4 hours during dialysis
Part of Kidney & urinary clinical trials.
This study tests a special filter called pHA130 that is used during your regular hemodialysis sessions for a full 4 hours. The purpose is to see if it helps improve your dialysis treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 75 years old
- On stable maintenance hemodialysis for at least 3 months
- Receiving dialysis 3 times a week, each session 4 hours or more
- Adequate dialysis clearance (spKt/V) measured at 1.2 or higher within the last 8 weeks
- Willing to sign a consent form
- Not have any serious health issues like active infections, cancer, bleeding disorders, or a life expectancy less than 1 year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
This study tests a long-term, high-flow hemoadsorption therapy for people on maintenance hemodialysis. It aims to see if the treatment can improve outcomes for those with uremia (built-up waste in the blood).
This study compares two forms of home peritoneal dialysis—how well they work for kidney health and how they affect daily life. You may be considered if you have end-stage kidney disease and meet specific test and safety requirements.
This trial tests a special blood-filtering treatment (hemoperfusion) for people with advanced kidney disease on regular dialysis. It aims to remove harmful substances that standard dialysis may not fully clear.
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
This trial tests a special dialysis filter (Elisio HX) that removes more waste products from the blood. It aims to see if this approach improves health outcomes for people on regular in-center hemodialysis.
Hear when a new End Stage Renal Disease on Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.